Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Jan / Optometric Aid
Glaucoma Retina Health Economics and Policy

Optometric Aid

Royal College of Optometrists’ study highlights the benefits of engaging optometrists in the management of nAMD and glaucoma in primary care settings

By The Ophthalmologist 1/28/2025 1 min read

Share

A recent study examining Welsh healthcare practices has explored the impact of shifting the management of neovascular age-related macular degeneration (nAMD) and glaucoma from hospital eye services (HES) to primary care optometrists. With hospital services facing increasing demand and longer waiting times in the UK, integrating optometrists into the care pathway could offer significant benefits to both patients and healthcare systems.

Conducted by The Royal College of Optometrists, the study evaluated seven enhanced optometric service pathways – three for nAMD and four for glaucoma – through a mixed-methods approach, including patient experience surveys, economic simulations, and workforce assessments. The results demonstrated that utilizing optometrists in primary care significantly reduced wait times for diagnosis and monitoring. For suspected nAMD cases, waiting times were recorded as having dropped to four-five days compared to lengthy hospital queues. Similarly, glaucoma patients experienced shorter waits of just five days, down from the typical two-year waiting period observed in hospital settings.

Patient satisfaction with primary care optometry services was found to be comparable to that of hospital services. Optometrists demonstrated the necessary qualifications and willingness to take on these expanded roles. Furthermore, the study found that consultant ophthalmologists' involvement in routine care decreased from 57 percent to 15 percent in nAMD services, and from 48 percent to 22 percent in glaucoma services, freeing up their time to focus on more complex cases.

Despite these identified benefits, challenges such as administrative coordination, IT support, and financial sustainability were also highlighted. The study emphasized that successful implementation requires clear communication between primary and secondary care providers, efficient referral systems, and strong administrative support to ensure seamless patient care.

If these challenges are addressed, the authors believe the study findings support expanding these services across Wales and potentially beyond, offering a scalable model to address the growing demands in ophthalmology.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: